Results 21 to 30 of about 12,019 (196)
BMC Cardiovascular Disorders, 2022 Background Neuropsychiatric side effects of cardiac drugs such as nervousness, mood swings and agitation may be misinterpreted as symptoms of anxiety.
Camilla Rotvig +10 more
doaj +1 more source
Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging [PDF]
, 2012 Knowledge about potential differences in infarct tissue characteristics between patients with prior life-threatening ventricular arrhythmia versus patients receiving prophylactic implantable cardioverter-defibrillator (ICD) might help to improve the ...
Birgelen, C. von +7 more
core +3 more sources
Atrial Flutter in a Newborn: a Case Report
Journal of Cardiovascular Emergencies, 2020 Introduction: The incidence of cardiac arrhythmia is approximately 1% in the neonatal period and 1–3% in late pregnancy. Atrial flutter (AF), a rhythm disorder based on the mechanism of reentry, represents approximately 32% of all neonatal cardiac ...
Cerghit Andreea Paler +6 more
doaj +1 more source
Successful management of massive lamotrigine extended‐release intoxication in a dog
Clinical Case Reports, 2021 A 3‐year‐old spayed female Siberian Husky presented for evaluation following ingestion of approximately 429 mg/kg of lamotrigine extended‐release. She demonstrated severe neurologic and cardiac signs and was treated with lipid emulsion, anticonvulsants ...
Alexis S. McLaine +3 more
doaj +1 more source
Медицинский совет, 2021 The article provides a scientific review based on the proceedings of the 2020 American Heart Association consensus on drugs that may cause arrhythmias on a risk-sensitive basis and a guidance on strategies for monitoring, prevention methods and ...
M. V. Leonova
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2022 ObjectiveWe investigated the effects of medication on heart disease and ischemic stroke (HDS) risk in patients with predominant bronchiectasis-asthma combination (BCAS).MethodsBCAS and non-BCAS cohorts (N = 588 and 1,118, respectively) were ...
Jun-Jun Yeh +9 more
doaj +1 more source
Tratamiento antiarrítmico actual de la fibrilación auricular no valvular en España: datos del Registro FANTASIIA [PDF]
, 2015 [Abstract] Introduction and objectives. Recently, there have been many developments in the management of nonvalvular atrial fibrillation, antiarrhythmic and anticoagulant therapy, and nonpharmacological treatment, but these developments are not applied ...
Anguita Sanchez, Manuel +10 more
core +2 more sources
Brugada Syndrome: Presentation and Management of the Atypical Patient in the Emergent Setting [PDF]
, 2020 Introduction: Brugada syndrome is a genetic disorder of the heart’s electrical system that increases a patient’s risk of sudden cardiac death. It is a syndrome most prevalent in Southeast Asians and is found 36 times more commonly in Asians than in ...
Flores, Mario +2 more
core
Should beta-blocker therapy be reduced or withdrawn after an episode of decompensated heart failure? Results from COMET. [PDF]
, 2007 BACKGROUND: It is unclear whether beta-blocker therapy should be reduced or withdrawn in patients who develop acute decompensated heart failure (HF). We studied the relationship between changes in beta-blocker dose and outcome in patients surviving a
A, +18 more
core +1 more source
Amiodarone-related Pneumonitis
Journal of the Formosan Medical Association, 2007 Amiodarone-related pneumonitis is a potentially limiting factor for amiodarone usage. However, it is believed that amiodarone-related pneumonitis is unlikely to occur during low-dose and short courses of therapy. We report three patients who received low-
Sheng-Nan Chang +7 more
doaj +1 more source